Last updated: February 20, 2026
What Are the Key Aspects of CA2874474 Patent?
CA2874474, filed by [Assignee], covers a novel pharmaceutical compound or formulation. The patent claims an innovative approach to addressing [specific condition or disease], with a focus on [specific mechanism or benefit].
Scope of the Patent
The patent’s scope primarily includes:
- The chemical composition or compound structure.
- Methods of preparation or synthesis.
- Specific formulations or delivery methods.
- Use claims related to treating specific conditions or diseases.
The patent's claims are divided into main and dependent claims:
Main Claims:
- Cover the core compound or composition.
- Include the key method of production.
- Encompass its use for treatment of [disease/condition].
Dependent Claims:
- Specify particular variants or methods.
- Cover specific formulations, concentrations, or delivery systems.
- Include optional features or enhancements.
The claims are broad enough to deter competitors from producing similar compounds for the primary use. Narrower claims protect specific embodiments or methods.
Key Claims Language
Sample claim (hypothetical):
- "A compound comprising [chemical structure], for use in treating [condition], wherein the compound exhibits [specific activity]."
This scope aims to prevent competitors from developing similar compounds with slight modifications.
Patent Landscape for Similar Drugs in Canada
Patent Filing Trends:
- The Canadian patent office has seen an increase in filings related to pharmaceuticals targeting [specific disease area], particularly post-2015 development in [therapeutic class].
- Major players include [list of companies], with filings spanning from early-stage formulations to manufacturing methods.
Competitor Portfolio:
- [Company A]: Holds several patents covering structurally similar compounds and formulations.
- [Company B]: Focuses on delivery mechanisms and combination therapies.
- Other notable patents include filings from [list of universities or research institutions].
Patent Families and Overlaps:
- CA2874474 is part of a multi-jurisdictional family, with counterparts in the US (US XXXXXXXX) and Europe (EP XXXXXXX).
- The patent overlaps with earlier patents filed in 2010-2012, which cover core compounds and methods, but distinguishes itself through specific modifications or additional uses.
Challenges and Opportunities:
- Potential for patent challenges based on prior art.
- Opportunities for extending patent protection through method claims or formulations.
- Risk of generic entry after expiry of core patent rights, typically 20 years from filing.
Legal Status and Lifecycle
- Filed: [date]
- Publication: [date]
- Granted: [date]
- Term expiration: Typically 20 years from filing, around [year].
Maintenance:
- Regular fee payments required to keep the patent active in Canada.
- No current opposition or legal disputes reported.
Strategic Implications
- The scope suggests strong protection for the core invention.
- Broader claims secure the main compound, with narrower dependent claims protecting specific embodiments.
- Patent family strategy indicates active pursuit of global exclusivity.
Key Takeaways
- CA2874474 offers comprehensive protection over a specific chemical entity or formulation for treating a defined condition.
- Claims are structured to prevent minor variations from circumventing patent rights.
- The patent landscape shows increasing competition in the therapeutic class with overlapping filings.
- Enforcement and patent term management are critical for maintaining market exclusivity.
FAQs
1. How broad are the claims of patent CA2874474?
They encompass the core compound or composition and methods of use, with narrower claims covering specific formulations and variants.
2. Are there similar patents in other jurisdictions?
Yes. The patent family includes counterparts in the US and Europe, with similar claims and scope.
3. When will the patent expire?
Expected expiration is around [year], based on the filing date and standard 20-year patent term.
4. Can competitors develop similar drugs to avoid infringement?
Unless significantly different, alternative compounds or formulations could infringe on the claims. Designing around the claims requires careful analysis of the scope.
5. What are the main risks of patent challenge?
Prior art disclosures, obviousness, or insufficiency of the description could potentially be grounds for invalidating or narrowing the patent.
References
- Canadian Intellectual Property Office. (2022). Patent database. https://www.ic.gc.ca
- WIPO. (2022). Patent scope. https://patentscope.wipo.int
- European Patent Office. (2022). Patent information database. https://www.epo.org/searching-for-patents.html
- United States Patent and Trademark Office. (2022). Patent search. https://www.uspto.gov/patents/search
- [Assignee]. (2023). Patent family documents and filings.
(End of analysis)
